ТОО "АЛЬ-МИҒРАЖ"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
1/17Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»Комитет государственных доходов · data as of 06.11.2026
This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses
Summary
Министерство юстиции РКActivities
1ОКЭДПрочая деятельность в области здравоохранения, не включенная в другие группировки
Contacts
Change history
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
1- ББ
Бекбергенов Бақдәулет Ерденұлы
Director
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
ТОО "АЛЬ-МИҒРАЖ" (BIN 210840009689) is an active legal entity in Шымкент, registered in 2021 (5 years on the market). Primary activity — прочая деятельность в области здравоохранения, не включенная в другие группировки. Automated screening found 1 risk indicator for "АЛЬ-МИҒРАЖ". Director on record — Бекбергенов Бақдәулет Ерденұлы. Data current as of November 6, 2026.
Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.